Shackelford Pharma Inc.

Reporting
CIK: 1811112•A1•Tier2

Equity (common or preferred stock) · Audited · Healthcare · SIC 2834

$22M
Qualified
maximum offering price, as qualified
$8.9M
Reported Sold
1-K 2022-01-26
12
Filings
across 3 offerings

Equity Classes

TypeClassOutstanding
commonVoting Common Shares45,463,767

Service Providers

RoleProvider
auditorDale Matheson Carr-Hilton Labonte LLP
legalNauth LPC, Farris LLP
promoterDealmaker

Offerings

File NumberFilingsFirst FiledLast FiledQualifiedCommencedPrice/SecuritySecurities OfferedSecurities SoldQualified SoldOutstandingAggregate OfferingProceeds ReportedEstimated NetSupplementsLast SupplementCRD
024-1194442022-07-212022-12-092022-12-12—$1.508,000,000——45,463,767$12M—$10.5M32023-02-02—
024-1120662020-05-042022-01-262020-08-202020-08-20$1.0010,000,0008,857,28810,000,00040,049,997$10M$8.9M$8.6M12020-08-21136352

Current Reports

Filing DateFormEventItems
2024-04-301-UDeparture of Officers7
Embarc dashboard

Operations, the balance sheet and cash flows as filed, year by year — the filer's own captions, not a mapped chart of accounts — plus the tagged figures from every Form 1-A family filing, plotted on the dates they were actually reported. EDGAR still has each 1-K; the dashboard lays every year they filed next to it.

  • Every caption as the filer wrote it, across every annual report — not just the latest 1-K
  • Tagged reported figures across every filing — revenue, assets, cash — with a sparkline on the actual filing dates
  • A sparkline on each annual-statement line, so the shape is visible before the figures
  • A revenue series dated to the filings that reported it
  • A filing history that says what each document contributed, not only that it exists
  • Follow it, and see it change on your watchlist
Open in the dashboard
External link: SEC Filings